Skip to main content Skip to search Skip to main navigation
Go to homepage

Seraseq® Whole Transcriptome RNA Seq Mix

Product information "Seraseq® Whole Transcriptome RNA Seq Mix"

Whole transcriptome RNA sequencing allows for the analysis of fusion genes with potential clinical utility that currently cannot be detected using the limited genomic coverage of targeted NGS panels. Additionally, some clinical cancer testing labs are evaluating whole transcriptome panels for improved diagnostic yields and clinical utilization for NGS-based tumor profiling test reimbursements. Expanding fusion gene content and higher detection efficiencies will expand use of fusion analysis in clinical NGS applications. Maybe most importantly is that new therapies are targeting fusion genes as clinical biomarkers for treatments of various adult and pediatric cancers.
Product type: Control & reference materials
Regulatory status: RUO
Content: 50 ng/µl
Quantity: 1 x 20 μl
Storage temperature: -70 °C
Shipping method: Dry ice
Country of distribution: Germany, Austria
Questions?
Get in touch with us. We look forward to helping you.
Seraseq® Whole Transcriptome RNA Seq Mix
€2,384.00*